https://www.selleckchem.com/products/acy-775.html
02), and higher mortality than younger patients (p = .02) complicated with rapidly progressive ILD (RP-ILD), combination immunosuppressive therapy, and strictly controlled infections.Conclusion Clinical features and mortality of anti-MDA5 autoantibody-positive DM patients were influenced by age. Patients aged ≥60 years had a worse prognosis, and combination immunosuppressive therapy was often ineffective for RP-ILD in older patients.Aim To describe the characteristics and medication treatment patterns, healthcare resource utilization (H
Like
Comment
Share
